192 related articles for article (PubMed ID: 27780854)
1. T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.
Wang T; Lu Y; Polk A; Chowdhury P; Murga-Zamalloa C; Fujiwara H; Suemori K; Beyersdorf N; Hristov AC; Lim MS; Bailey NG; Wilcox RA
Clin Cancer Res; 2017 May; 23(10):2506-2515. PubMed ID: 27780854
[No Abstract] [Full Text] [Related]
2. ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.
Jiang B; Weinstock DM; Donovan KA; Sun HW; Wolfe A; Amaka S; Donaldson NL; Wu G; Jiang Y; Wilcox RA; Fischer ES; Gray NS; Wu W
Cell Chem Biol; 2023 Apr; 30(4):383-393.e6. PubMed ID: 37015223
[TBL] [Abstract][Full Text] [Related]
3. B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.
Zhang L; Nomie K; Zhang H; Bell T; Pham L; Kadri S; Segal J; Li S; Zhou S; Santos D; Richard S; Sharma S; Chen W; Oriabure O; Liu Y; Huang S; Guo H; Chen Z; Tao W; Li C; Wang J; Fang B; Wang J; Li L; Badillo M; Ahmed M; Thirumurthi S; Huang SY; Shao Y; Lam L; Yi Q; Wang YL; Wang M
Clin Cancer Res; 2017 Aug; 23(15):4212-4223. PubMed ID: 28348046
[No Abstract] [Full Text] [Related]
4. Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma.
Sniderhan LF; Garcia-Bates TM; Burgart M; Bernstein SH; Phipps RP; Maggirwar SB
Exp Hematol; 2009 Nov; 37(11):1295-309. PubMed ID: 19716854
[TBL] [Abstract][Full Text] [Related]
5. IL-2-inducible T-cell kinase (ITK) finds another (dance) partner...TFII-I.
August A
Eur J Immunol; 2009 Sep; 39(9):2354-7. PubMed ID: 19688746
[TBL] [Abstract][Full Text] [Related]
6. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.
Dierks C; Adrian F; Fisch P; Ma H; Maurer H; Herchenbach D; Forster CU; Sprissler C; Liu G; Rottmann S; Guo GR; Katja Z; Veelken H; Warmuth M
Cancer Res; 2010 Aug; 70(15):6193-204. PubMed ID: 20670954
[TBL] [Abstract][Full Text] [Related]
7. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways.
Costello PS; Walters AE; Mee PJ; Turner M; Reynolds LF; Prisco A; Sarner N; Zamoyska R; Tybulewicz VL
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3035-40. PubMed ID: 10077632
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the cell survival/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization.
Vega MI; Martínez-Paniagua M; Huerta-Yepez S; González-Bonilla C; Uematsu N; Bonavida B
Int J Oncol; 2009 Dec; 35(6):1289-96. PubMed ID: 19885551
[TBL] [Abstract][Full Text] [Related]
9. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
[TBL] [Abstract][Full Text] [Related]
10. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
11. RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer.
Goka ET; Chaturvedi P; Lopez DTM; Garza A; Lippman ME
Mol Cancer Ther; 2019 May; 18(5):957-968. PubMed ID: 30926638
[TBL] [Abstract][Full Text] [Related]
12. TCR and CD28 activate the transcription factor NF-κB in T-cells via distinct adaptor signaling complexes.
Thaker YR; Schneider H; Rudd CE
Immunol Lett; 2015 Jan; 163(1):113-9. PubMed ID: 25455592
[TBL] [Abstract][Full Text] [Related]
13. A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
Boonstra PS; Polk A; Brown N; Hristov AC; Bailey NG; Kaminski MS; Phillips T; Devata S; Mayer T; Wilcox RA
Am J Hematol; 2017 Dec; 92(12):1287-1294. PubMed ID: 28842936
[TBL] [Abstract][Full Text] [Related]
14. GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.
Mondragón L; Mhaidly R; De Donatis GM; Tosolini M; Dao P; Martin AR; Pons C; Chiche J; Jacquin M; Imbert V; Proïcs E; Boyer L; Doye A; Luciano F; Neels JG; Coutant F; Fabien N; Sormani L; Rubio-Patiño C; Bossowski JP; Muller F; Marchetti S; Villa E; Peyron JF; Gaulard P; Lemonnier F; Asnafi V; Genestier L; Benhida R; Fournié JJ; Passeron T; Ricci JE; Verhoeyen E
Cancer Cell; 2019 Sep; 36(3):268-287.e10. PubMed ID: 31447347
[TBL] [Abstract][Full Text] [Related]
15. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
[TBL] [Abstract][Full Text] [Related]
16. Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas.
Islam S; Qi W; Morales C; Cooke L; Spier C; Weterings E; Mahadevan D
Mol Cancer Ther; 2017 Oct; 16(10):2083-2093. PubMed ID: 28615297
[TBL] [Abstract][Full Text] [Related]
17. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk.
Liao XC; Littman DR
Immunity; 1995 Dec; 3(6):757-69. PubMed ID: 8777721
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas.
Kitadate A; Ikeda S; Abe F; Takahashi N; Shimizu N; Matsue K; Tagawa H
Haematologica; 2018 Jan; 103(1):126-135. PubMed ID: 29025909
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.
Maxwell SA; Mousavi-Fard S
Exp Biol Med (Maywood); 2013 Sep; 238(9):971-90. PubMed ID: 23986223
[TBL] [Abstract][Full Text] [Related]
20. Correction: T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 Axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.
Clin Cancer Res; 2017 Oct; 23(19):5995. PubMed ID: 28972087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
